GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (OTCPK:RDTCF) » Definitions » Other Operating Expense

RDTCF (Rapid Dose Therapeutics) Other Operating Expense : $0.28 Mil (TTM As of Nov. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Rapid Dose Therapeutics Other Operating Expense?

Rapid Dose Therapeutics's Other Operating Expense for the three months ended in Nov. 2024 was $0.04 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Nov. 2024 was $0.28 Mil.

Rapid Dose Therapeutics's quarterly Other Operating Expense declined from May. 2024 ($0.06 Mil) to Aug. 2024 ($0.04 Mil) and declined from Aug. 2024 ($0.04 Mil) to Nov. 2024 ($0.04 Mil).

Rapid Dose Therapeutics's annual Other Operating Expense declined from Feb. 2022 ($0.60 Mil) to Feb. 2023 ($0.49 Mil) and declined from Feb. 2023 ($0.49 Mil) to Feb. 2024 ($0.45 Mil).


Rapid Dose Therapeutics Other Operating Expense Historical Data

The historical data trend for Rapid Dose Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Other Operating Expense Chart

Rapid Dose Therapeutics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.59 0.60 0.49 0.45

Rapid Dose Therapeutics Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.15 0.06 0.04 0.04

Rapid Dose Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rapid Dose Therapeutics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Rapid Dose Therapeutics Business Description

Traded in Other Exchanges
Address
1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.

Rapid Dose Therapeutics Headlines